Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Genentech Inc. Stories

2014-02-03 08:27:04

INCLINE VILLAGE, Nev., Feb. 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd. (Roche) which resolves all outstanding legal disputes between the parties, including its Nevada litigation with Genentech and Roche and its arbitration proceedings with Genentech related to the audit of royalties on sales. (Logo:...

2013-04-25 08:35:22

Genentech Ranks Highest in Physician Satisfaction with Biopharmaceutical Manufacturers WESTLAKE VILLAGE, Calif., April 25, 2013 /PRNewswire/ -- Although the role of pharmaceutical sales representatives has changed in recent years, physicians continue to perceive the sales representative as the leading influence on their relationship with biopharmaceutical companies, according to the J.D. Power and Associates 2013 Physician Manufacturer Experience Study--Oncology(SM )released today....

2012-01-03 06:00:00

TARRYTOWN, N.Y, Jan. 3, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Company has entered into a non-exclusive license and partial settlement agreement (Agreement) with Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) relating to U.S. ophthalmic sales of EYLEA(TM) (aflibercept) Injection. Regeneron received a non-exclusive license to certain patents relating to VEGF receptor proteins, known as the Davis-Smyth patents,...

2011-11-21 08:00:00

TARRYTOWN, N.Y., Nov. 21, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it has elected Marc Tessier-Lavigne, Ph.D. to fill a new seat on its expanded Board of Directors. Dr. Tessier-Lavigne is President of The Rockefeller University in New York City, one of the world's preeminent medical research institutions. Prior to his appointment at Rockefeller in 2011, he served as Executive Vice President and Chief Scientific Officer at Genentech,...

2011-11-09 15:00:00

INCLINE VILLAGE, Nev., Nov. 9, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the third quarter ended September 30, 2011. (Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO) Revenues Total revenues for the third quarter of 2011 were $83.8 million, compared to $86.4 million for the same period of 2010, a three percent year-over-year decrease. Total revenues for the nine months ended September 30, 2011, were $289.2 million,...

2011-09-13 09:40:00

DES PLAINES, Ill., Sept. 13, 2011 /PRNewswire-USNewswire/ -- The Emergency Nurses Association (ENA) today announced the corporate sponsors for the ENA Annual Conference to be held in Tampa on September 20-24, 2011. This year's Strategic Sponsors are Stryker and Vidacare; the Strategic Supporters are GE Healthcare and Hill-Rom; and the Annual Conference Supporters are American Heart Association, FreemanWhite ED Design Team, Gebauer Company, Genentech Inc., Philips Healthcare and...

2011-08-24 08:02:00

SAN FRANCISCO, Aug. 24, 2011 /PRNewswire/ -- Taptera, a leading developer of Apple mobile enterprise apps, today announced it has secured $2 million in Series A funding led by prominent Silicon Valley investor Terence Garnett. Other participants in the round include salesforce.com and an impressive array of leading CEOs, Silicon Valley investors and luminaries including M.R. Rangaswami and David Murphy. Garnett will also join the company's board of directors. Taptera will use the funding...

2011-02-28 15:00:00

INCLINE VILLAGE, Nev., Feb. 28, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2010. Total revenues in 2010 were $345.0 million, compared to $318.2 million in 2009. Excluding 2009 royalty revenues for sales of Synagis® received from MedImmune, royalty revenues for 2010 increased 30 percent over 2009. For the fourth quarter of 2010, total revenues were $76.1 million,...

2011-02-11 15:19:00

FAIRFIELD, N.J., Feb. 11, 2011 /PRNewswire-USNewswire/ -- The Healthcare Businesswomen's Association (HBA) today announced that it has named Ian T. Clark, Genentech's chief executive officer and head of North American commercial operations, as its 2011 Honorable Mentor. He will be formally recognized at the 22nd annual "Woman of the Year" (WOTY) Luncheon on Thursday, May 5, 2011 - the premier event of the year for the healthcare community, attended by over 2,000 industry leaders. (Logo:...

2010-11-08 15:16:00

SUNNYVALE, Calif., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported recent developments and financial results for its fiscal first quarter which ended September 30, 2010. Recent Developments & Highlights Three distinguished individuals nominated to join our Board of Directors: Gwen A. Fyfe, M.D. is an oncology biotechnology veteran with more than 20 years of drug development experience. From 1997 to 2009, Dr. Fyfe was an employee of...